James (Jim) Dunyak, Ph.D., is VP, Biostatistics at Acrivon Therapeutics, Inc. Previously, he was the Senior Director of Biostatistics at Certara. From 2015-2021, Jim served as the Senior Director of Clinical Pharmacometrics at AstraZeneca responsible for identifying opportunities to utilize innovative trial designs and statistical analysis methods in drug development. At Metamark Genetics, he held increasing roles of responsibility including most recently Head of Research and Development managing the R&D department. Earlier in his career, Jim held senior roles at Novartis, MITRE Corporation, and the Naval Research Laboratory. Additionally, he served as a tenured Associate Professor in the Department of Mathematics and Statistics at Texas Tech. Jim holds multiple degrees, including a B.S. from Virginia Tech, a M.S. in Engineering Mechanics from Virginia Polytechnic Institute, a Ph.D. in Applied Mathematics/Probability Theory from University of Maryland, a M.S. in Biostatistics from the Harvard T.H. Chan School of Public Health, and a M.S. in Regulatory Affairs from Northeastern University.